Friday, December 29, 2023 5:01:05 PM
What a sad lapse in scientific writing. Indeed what a sad lapse in truthful writing.
Brilacidin has shown an unpleasant toxicity profile in every clinical study performed, with peripheral neuropathy and/or hypertensive spikes shown in the majority of subjects unfortunate enough to receive the drug candidate. Here's just one study that demonstrates that:
As for efficacy, in the clinical study in COVID-19 brilacidin was shown not only to add zero benefit to standard of care, it actually showed a clear trend towards delaying time to recovery, as well as adding toxicity that was unnecessary by definition (https://classic.clinicaltrials.gov/ct2/show/results/NCT04784897?term=brilacidin&draw=2&rank=2).
The authors of that piece have either failed to perform even a rudimentary minimum of literature review to substantiate their piece, or are very dishonest.
I hope it's the former although I suspect we all know who has influenced their research and that individual's unreasonable adherence to his "brainchild".
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM